Stay updated with breaking news from Agenus. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
LONDON (dpa-AFX) - Genus plc (GNS.L), on Tuesday, issued trading update for the period from 1 January 2023 to 30 April 2023, and revised outlook for the 2023 fiscal year.The company noted that
Animal genetics company Genus cut its full-year profit outlook on Tuesday as it pointed to "very challenging" market conditions in the porcine business in China.
Genus (LON:GNS – Get Rating)‘s stock had its “buy” rating reiterated by research analysts at Peel Hunt in a report issued on Tuesday, Digital Look reports. They presently have a GBX 4,500 ($56.37) price objective on the stock. Peel Hunt’s price target would suggest a potential upside of 76.89% from the company’s previous close. Genus […]
Agenus Inc. (NASDAQ:AGEN – Get Rating) major shareholder Agenus Inc purchased 22,065 shares of the stock in a transaction on Wednesday, May 10th. The stock was acquired at an average price of $1.51 per share, with a total value of $33,318.15. Following the acquisition, the insider now directly owns 21,617,112 shares in the company, valued […]
Agenus Inc. (NASDAQ:AGEN – Get Rating) was the recipient of a large decline in short interest in April. As of April 30th, there was short interest totalling 19,550,000 shares, a decline of 18.1% from the April 15th total of 23,880,000 shares. Based on an average daily volume of 5,150,000 shares, the short-interest ratio is presently […]